A clinical trial is run to investigate the effectiveness of an experimental drug in reducing preterm delivery to a drug considered standard care and to a placebo. Pregnant women are enrolled and randomly assigned to receive either the experimental drug, the standard drug or a placebo. Women are followed through delivery and classified as delivering preterm (< 37 weeks) or not. The data are shown below.

Preterm Delivery	Experimental Drug	Standard Drug	Placebo
Yes	15	23	40
No	83	79	67

Is there a statistically significant difference in the proportions of women delivering preterm among the three treatment groups? Run the test at a 5% level of significance.